An Observational Study on the Adherence to Treatment Guidelines of Osteopenia

Buencamino, Maria Clarinda A.; Sikon, Andrea; Jain, Anil; Thacker, Holly L.

doi:10.1089/jwh.2008.0897

Cited by 17 publications

(20 citation statements)

References 35 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although osteoporosis affects both older men and women, postmenopausal women have been the primary focus of osteoporosis (Buencamino et al, 2009;Schmitt et al, 2009). A dramatic deficiency of female hormone is the most important factor to postmenopausal women osteoporosis.…”

Section: Discussionmentioning

confidence: 99%

“…Most cases of osteoporosis occur in postmenopausal women due to the dramatic estrogen withdrawal associated with menopause. In America, it threats an estimated 44 million people, or 55 percent of the people of 50 years of age and older (Buencamino et al, 2009). In Europe, osteoporosis related fractures accounts for more disability-adjusted life years (DALYs) lost than common cancers except for lung cancer (Johnell and Kanis, 2006).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Osteoprotective effect of extract from Achyranthes bidentata in ovariectomized rats

Hui

Tezuka

et al. 2010

Journal of Ethnopharmacology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Osteoprotective effect of extract from Achyranthes bidentata in ovariectomized rats

Hui

Tezuka

et al. 2010

Journal of Ethnopharmacology

View full text Add to dashboard Cite

“…The National Osteoporosis Foundation (NOF) has recommendations for prevention and treatment of low BMD; however, the condition remains underrecognized and undertreated [6].…”

Section: Description Of Osteoporosis Osteopenia and Periodontal Diseasementioning

confidence: 99%

Osteoporosis and oral bone resorption: a review

Ardakani

Mirmohamadi

2009

J. Maxillofac. Oral Surg.

View full text Add to dashboard Cite

This paper is a summary of the published studies on the possible association between osteoporosis and alveolar bone loss. Osteoporosis and low bone mass are considered as a major public health problem. The mandible like other bones of the body has a series of anatomical landmarks that can serve as radiographic indicators. Using these indicators it is possible to evaluate changes in bone with respect to its quantity or quality by different methods of taking images. Higher bone resorption was detected in women with a higher number of pregnancies. Also, the higher educated the patient, the less bone resorption. Women with a background of backaches had more bone resorption to those who did not have this backache background. Finally, it was recognized that it would be possible to clear the quality dimension of the process of mandibular bone resorption. If we can identify the osteoporotic process using a basic panoramic radiography measurement technique, then it is possible to intercept the progress of the disease through early warning and treatment. From the results of this study, it can be concluded the thickness of the mandibular angular cortex can be used as an index for bone resorption. A healthy lifestyle has multiple benefits for the mouth and throughout the body. Dental professionals can play a role in preventing osteoporosis by reinforcing this message.

show abstract

“…3,4 Effective treatment of osteopaenia before the development of osteoporosis would be of great clinical importance and would also be economically relevant, as early therapeutic intervention for low bone mass decreases the risk of bone fractures and, therefore, their associated medical costs. 5 Whether patients who have osteopaenia but no fractures should be treated with antiresorptive drugs, however, remains controversial; 6 -9 data on use of antiresorptive drugs in this way are scant.…”

Section: Introductionmentioning

confidence: 99%

The Safety and Efficacy of Early-Stage Bi-Weekly Alendronate to Improve Bone Mineral Density and Bone Turnover in Chinese Post-Menopausal Women at Risk of Osteoporosis

Chen

et al. 2011

J Int Med Res

View full text Add to dashboard Cite

The efficacy and safety of early, low frequency antiresorptive drug intervention for osteopaenia on bone mineral density (BMD) and bone turnover in Chinese post-menopausal women at risk of developing osteoporosis were investigated. A total of 180 women aged 40 -70 years were enrolled and equally randomized to receive either 70 mg alendronate once every 2 weeks plus 0.5 µg alfacalcidol daily (treatment group) or alfacalcidol 0.5 µg daily alone (control group) for 12 months. In the treatment group, lumbar spine and total hip BMD at 12 months had increased significantly from baseline and compared with the control group. There were also significant reductions in serum levels of the bone turnover biomarkers, bone-specific alkaline phosphatase and C-terminal telopeptide of type I collagen, compared with the control. No serious adverse events were observed in either group and safety profiles were similar. It was concluded that early intervention with 70 mg alendronate once every 2 weeks was safe, well tolerated and more effective than alfacalcidol alone (control) in increasing BMD and reducing bone turnover, and might prevent serious outcomes, such as fragility fractures, reduce rates of adverse effects and improve patient compliance.

show abstract

An Observational Study on the Adherence to Treatment Guidelines of Osteopenia

Abstract: Osteopenia is adequately managed in our institution regardless of physician group. However, non-bone specialists should consider more direct counseling about bone health and consider advisement of weightbearing exercise.

Cited by 17 publications

References 35 publications

Osteoprotective effect of extract from Achyranthes bidentata in ovariectomized rats

Osteoprotective effect of extract from Achyranthes bidentata in ovariectomized rats

Osteoporosis and oral bone resorption: a review

The Safety and Efficacy of Early-Stage Bi-Weekly Alendronate to Improve Bone Mineral Density and Bone Turnover in Chinese Post-Menopausal Women at Risk of Osteoporosis

Contact Info

Product

Resources

About